Development of Selective Cyclin-Dependent Kinase 4 Inhibitors for Antineoplastic Therapies. (Record no. 26748241)

MARC details
000 -LEADER
fixed length control field 01372 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517132616.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201709s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1875-5992
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.2174/1871520617666170103095527
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Guan, Haixing
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20170905
245 00 - TITLE STATEMENT
Title Development of Selective Cyclin-Dependent Kinase 4 Inhibitors for Antineoplastic Therapies.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Anti-cancer agents in medicinal chemistry
Date of publication, distribution, etc. 2017
300 ## - PHYSICAL DESCRIPTION
Extent 646-657 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision chemistry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Proliferation
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclin-Dependent Kinase 4
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Screening Assays, Antitumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Models, Molecular
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Molecular Structure
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision chemistry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Structure-Activity Relationship
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Du, Yongli
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Han, Weiwei
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shen, Jingkang
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Li, Qunyi
773 0# - HOST ITEM ENTRY
Title Anti-cancer agents in medicinal chemistry
Related parts vol. 17
-- no. 5
-- p. 646-657
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.2174/1871520617666170103095527">https://doi.org/10.2174/1871520617666170103095527</a>
Public note Available from publisher's website

No items available.